ATP11A is a novel predictive marker for metachronous metastasis of colorectal cancer

Oncology Reports

Volumn 23, Issue 2, 2010, Pages 505-510

  Miyoshi, Norikatsu ^a   Ishii, Hideshi ^a,b   Mimori, Koshi ^b   Tanaka, Fumiaki ^b   Nagai, Kennichi ^a   Uemura, Mamoru ^a   Sekimoto, Mitsugu ^a   Doki, Yuichiro ^a   Mori, Masaki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

ATP11A; Colorectal cancer; Metastasis

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE 11A; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADENOSINE TRIPHOSPHATASES; ADULT; AGED; AGED, 80 AND OVER; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 76649130569     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000662     Document Type: Article

References (14)

1. Kohno SI, Luo C, Nawa A, et al: Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus. Cancer Gene Ther 14: 918-926, 2007.
2. Bathe OF, Dowden S, Sutherland F, et al: Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma. BMC Cancer 4: 32, 2004.
3. Kornmann M, Formentini A, Ette C, et al: Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment. Eur J Surg Oncol 34: 1316-1321, 2008.
4. Wolpin BM and Mayer RJ: Systemic treatment of colorectal cancer. Gastroenterology 134: 1296-1310, 2008.
5. Gottesman MM, Fojo T and Bates SE: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2: 48-58, 2002.
6. Zhang B, Groffen J and Heisterkamp N: Resistance to farnesyltransferase inhibitors in Bcr/Abl-positive lymphoblastic leukemia by increased expression of a novel ABC transporter homolog ATP11a. Blood 106: 1355-1361, 2005.
7. Sobin LH and Fleming ID: TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80: 1803-1804, 1997.
8. Mimori K, Mori M, Shiraishi T, et al: Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma. Br J Cancer 76: 531-536, 1997.
9. Mori M, Staniunas RJ, Barnard GF, Jessup JM, Steele GD Jr and Chen LB: The significance of carbonic anhydrase expression in human colorectal cancer. Gastroenterology 105: 820-826, 1993.
10. Halleck MS, Lawler JJ, Blackshaw S, et al: Differential expression of putative transbilayer amphipath transporters. Physiol Genomics 1: 139-150, 1999.
11. Jayne DG, Guillou PJ, Thorpe H, et al: Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 25: 3061-3068, 2007.
12. Lacy AM, Garcia-Valdecasas JC, Delgado S, et al: Laparoscopyassisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 359: 2224-2229, 2002.
13. Weeks JC, Nelson H, Gelber S, Sargent D and Schroeder G: Short-term quality-of-life outcomes following laparoscopicassisted colectomy vs open colectomy for colon cancer: a randomized trial. JAMA 287: 321-328, 2002.
14. Clinical Outcomes of Surgical Therapy Study Group: A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 350: 2050-2059, 2004.